A carregar...
Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study)
OBJECTIVE: To investigate the efficacy and safety of the interleukin-6 receptor antibody tocilizumab in patients with Takayasu arteritis (TAK). METHODS: Patients with TAK who had relapsed within the previous 12 weeks were induced into remission with oral glucocorticoid therapy. In this double-blind,...
Na minha lista:
| Publicado no: | Ann Rheum Dis |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5867398/ https://ncbi.nlm.nih.gov/pubmed/29191819 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2017-211878 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|